Do no harm: A paradigm shift in the unchecked use of antidepressants

CNS Spectrums

Volumn 22, Issue 2, 2017, Pages 118-119

  Morrissette, Debbi Ann ^a  

^a NEUROSCIENCE EDUCATION INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; MOOD STABILIZER; NEUROLEPTIC AGENT;

ADOLESCENT; BIPOLAR I DISORDER; CASE REPORT; CONVERSATION; DEPRESSION; EDITORIAL; HUMAN; HYPOMANIA; MAJOR DEPRESSION; MALE; MANIA; MONOTHERAPY; QUESTIONNAIRE; SUICIDAL IDEATION; BIPOLAR DISORDER; CHEMICALLY INDUCED; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; GENETIC PREDISPOSITION; GENETICS; MASS SCREENING; PROTOCOL COMPLIANCE; PSYCHOLOGY;

ADOLESCENT; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC ERRORS; GENETIC PREDISPOSITION TO DISEASE; GUIDELINE ADHERENCE; HUMANS; MALE; MASS SCREENING;

EID: 85011796910     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852917000086     Document Type: Editorial

References (1)

1. Stahl SM, Morrissette DA, Faedda G, et al. Guidelines for the recognition and management of mixed depression. CNS Spectr. 2017; 22(2): 203-219.